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Discussion:

Abstract:
Scrotal edema is not an uncommon presentation in emergency medicine. We describe the case of a
58-year-old male with no prior medical history who presented to the emergency department (ED) due
to progressive scrotal edema. The patient noted increased painless testicular enlargement, dry cough,
and dyspnea on exertion over the course of several weeks. Scrotal edema was evaluated by an
Ultrasound (US), showing bilateral testicular edema with concern for congestive heart failure (CHF).
Computed tomography pulmonary angiography (CTPE) scan showed a large 6.51 cm thoracic aortic
aneurysm (TAA), cardiomegaly with dilated left sided chambers, and a small pericardial effusion.
Subsequently, the patient had a transthoracic echocardiogram (TTE) and was found to have left
ventricular ejection fraction of 35% with severe aortic regurgitation, causing heart failure. Patient was
transferred to the operating room (OR) for an aortic valve, aortic root, and ascending aorta
replacement. Patient was deemed medically stable for discharge to home 2 weeks after initial TAA
findings. TAA is a silent disease and an important cause of mortality in adults. Early recognition by
astute clinicians can significantly reduce morbidity and mortality.

Introduction:
Painless scrotal edema in adults has many causes including congestive heart failure, fluid retention,
epididymitis, orchitis, hernia, hydrocele, varicocele, injury, testicular torsion, and testicular cancer [1].
Scrotal edema can be secondary to an underlying pathology outside of the scrotum itself. Here we
describe an unusual case of a painless scrotal edema that was provoked as a result of a large TAA
causing severe aortic regurgitation leading to acute CHF.

Case Presentation:
A 58-year-old male presented to the ED with a complaint of scrotal edema which had been ongoing for
the past 8 weeks and was associated with intermittent dyspnea on exertion, dry cough, and weight
gain. He denied chest pain, shortness of breath at rest, abdominal pain, recent sexual activity,
testicular pain, trauma, penile discharge, urinary output changes, or dysuria. He denied any medical
conditions or any prior surgeries. He did not take any medications daily. His last physician evaluation
occurred 20 years prior to this presentation. Social history was negative for tobacco, alcohol, and drug
use.
On presentation, his vital signs were blood pressure of 140/85 mm Hg, heart rate of 117 beats per
minute (bpm), respiratory rate of 18 breaths per minute, temperature 98.7 degrees Fahrenheit orally,
and a pulse oximetry of 95% on room air. His Body Mass Index was 26.5 kg/M2. Physical examination
revealed non-toxic appearing, well appearing male. On auscultation, he had a 4/6 diastolic ejection
murmur with loud decrescendo at the left lower sternal border. There was jugular venous distension
and crackles at the bases of the lungs with decreased breath sounds at the right base. He had bilateral
(b/l) scrotal edema without erythema, ecchymosis, pain, or lesions. Lower extremities had non-pitting
edema without calf tenderness, capillary refill of less than 2 seconds, with palpable b/l dorsalis pedis
and posterior tibial pulses. Otherwise, the examination was unremarkable.
A chest X-ray (CXR) performed showed trace right pleural effusion, cardiomegaly, and mild central
vascular congestion. An electrocardiogram showed atrial fibrillation with rapid ventricular response at
128 bpm, left ventricular hypertrophy, without acute ST segment or T wave changes. Laboratory
studies completed revealed B-type natriuretic peptide of 1715 and a high sensitivity troponin of 58. A
complete blood count and basic metabolic panel were unremarkable. Urinalysis was noted to have 1+
protein, otherwise negative. Ultrasound of scrotum and testicles revealed diffuse scrotal wall edema
with small b/l hydroceles, without evidence of intratesticular mass or torsion. Ultrasound of b/l lower
extremities showed no evidence of deep vein thrombosis. Patient appeared clinically in acute CHF, but
with new onset atrial fibrillation, lower extremity edema, dyspnea on exertion, and oxygen saturation
of 95%, CTPE study was ordered to rule out a pulmonary embolism. CTPE showed a large 6.51 cm TAA,
cardiomegaly with dilated left sided chambers, and a small pericardial effusion (Figure 1). After
consultation with cardiothoracic surgery, the patient was started on heparin, and urgently taken to
the OR for an aortic valve, aortic root, and ascending aorta replacement. Post-operative course was
complicated by an episode of ventricular fibrillation relieved by a brief period of cardiopulmonary
resuscitation. After 14 days in the hospital, the patient was deemed medically stable for discharge to
home on Eliquis and Metoprolol.

Figure 1: CTPE showing a TAA measuring 6.51 cm

TAA and its associated complications rank in the top 20 leading causes of mortality in the United States
and the 15th leading cause of death in people over the age of 65. As Clouse et al. pointed out, the
mortality rates of patients presenting with TAA has remained high even if they are treated before
complications occur [2].
The incidence of TAA has been reported to be 6-13 cases per 100,000 per year, however mortality is
extremely high, with rates of 57% without surgery and 17% to 25% with surgery [3]. Many acquired,
congenital, and hereditary etiologies of TAA have been implicated but will not be reviewed in this case
report.
Dilatation of the ascending aorta is a very indolent process as it takes many years to develop. Typically,
patients are asymptomatic until either a catastrophic event occurs or it is incidentally found on
cardiovascular imaging. TAA can be complicated by aortic dissection or rupture, cardiac tamponade,
pericardial hemorrhage, and occlusion of aortic branches [4]. There are many imaging modalities for
evaluation of TAA including CXR, Transthoracic Echocardiography (TTE), Computed Tomography (CT),
and Magnetic Resonance Imaging (MRI). Typical CXR findings include widening of the mediastinum,
however, CXRs have been found to be normal 15-20% of the time. TTE is a simple non-invasive
technique that can be used to evaluate the aortic root, proximal ascending aorta, aortic valve, left
ventricular morphology and function. TTE is the recommended imaging modality for screening of
patients with suspected TAA and for follow-up [5]. CT angiography is the preferred imaging modality
due to ease of accessibility and rapid results. It allows for visualization of aortic anatomy and its
branching vessels with sensitivity and specificity reaching up to 100%. Cardiac MRI, allows for better
assessment of aortic root anatomy, ventricular and aortic valve function, though it is less accessible and
more time consuming then other modalities [6].
Clinical guidelines suggest that the size of the ascending aorta and root should be evaluated every 6 to
12 months. Imaging studies are recommended more frequently, every 3 to 6 months, when the aorta
exceeds 4.5 cm or the growth rate is greater than 0.5 cm per year [7]. Elective surgical repair remains
the mainstay for the management of symptomatic aneurysm or asymptomatic aneurysm of which the
diameter is greater than 5.5 cm [8]. Secondary management of TAA includes lifestyle modification,
serial imaging, and medical treatment with beta blockers, maintaining blood pressure under 130/80 mm
Hg in those with diabetes or chronic renal disease and 140/90 mm Hg in those without [9].

Conclusions:
TAA is a lethal disease. Complications of TAA can be disastrous even if diagnosed promptly and
properly managed. Here we describe a case of a 58-year-old male with scrotal edema as a result of
heart failure from a large TAA. Early diagnosis of TAA and arrangement for proper follow-up, medical
management, and surgical treatment on a non-emergent basis leads to improved clinical outcomes
and can prevent vascular catastrophes for individual patients.
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